1. Home
  2. TPC vs PCRX Comparison

TPC vs PCRX Comparison

Compare TPC & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPC
  • PCRX
  • Stock Information
  • Founded
  • TPC 1894
  • PCRX 2006
  • Country
  • TPC United States
  • PCRX United States
  • Employees
  • TPC N/A
  • PCRX N/A
  • Industry
  • TPC General Bldg Contractors - Nonresidential Bldgs
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TPC Consumer Discretionary
  • PCRX Health Care
  • Exchange
  • TPC Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • TPC 1.0B
  • PCRX 1.2B
  • IPO Year
  • TPC N/A
  • PCRX 2011
  • Fundamental
  • Price
  • TPC $37.85
  • PCRX $26.24
  • Analyst Decision
  • TPC Strong Buy
  • PCRX Buy
  • Analyst Count
  • TPC 2
  • PCRX 9
  • Target Price
  • TPC $40.50
  • PCRX $29.89
  • AVG Volume (30 Days)
  • TPC 742.7K
  • PCRX 891.6K
  • Earning Date
  • TPC 05-07-2025
  • PCRX 05-08-2025
  • Dividend Yield
  • TPC N/A
  • PCRX N/A
  • EPS Growth
  • TPC N/A
  • PCRX N/A
  • EPS
  • TPC N/A
  • PCRX N/A
  • Revenue
  • TPC $4,524,568,000.00
  • PCRX $702,772,000.00
  • Revenue This Year
  • TPC $19.51
  • PCRX $8.63
  • Revenue Next Year
  • TPC $14.66
  • PCRX $11.66
  • P/E Ratio
  • TPC N/A
  • PCRX N/A
  • Revenue Growth
  • TPC 8.95
  • PCRX 3.08
  • 52 Week Low
  • TPC $14.50
  • PCRX $11.16
  • 52 Week High
  • TPC $37.79
  • PCRX $31.64
  • Technical
  • Relative Strength Index (RSI)
  • TPC 77.05
  • PCRX 55.27
  • Support Level
  • TPC $36.22
  • PCRX $25.33
  • Resistance Level
  • TPC $37.77
  • PCRX $26.44
  • Average True Range (ATR)
  • TPC 1.18
  • PCRX 0.94
  • MACD
  • TPC -0.05
  • PCRX 0.02
  • Stochastic Oscillator
  • TPC 100.00
  • PCRX 81.79

About TPC Tutor Perini Corporation

Tutor Perini Corp offers general contracting, construction management, and design-build services to private and public customers. The company constructs and repairs transportation infrastructure, water-treatment facilities, and a wide range of buildings. Tutor Perini has three operating segments: Civil, Building, and Specialty Contractors. A majority of its revenue is generated from the Civil segment, which specializes in public works construction and the replacement and reconstruction of infrastructure. Its civil contracting services include construction and rehabilitation of highways, bridges, tunnels, mass-transit systems, military and other government facilities, and water management and wastewater treatment facilities. Geographically, it derives key revenue from the United States.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: